VisszavonvaFázis nélkül
Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA
A legfontosabb adatok
- Ki végzi
- Yale University
- Hol
- New Haven (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Visszavonva
- Kezdés
- 2025. dec.
- Várható befejezés
- 2030. jún.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A vizsgált kezelések
- Blood draw to measure the levels of dd-cf DNA
- A regiszteradat frissítve
- 2025. november 6.
- Miért állt le
- Protocol was not approved by the sponsor; therefore PI not moving forward with this study.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 12 feltétel megnézéseKevesebb
Ki nem vehet részt
- Multiorgan transplantation
- Less than 3 years from transplantation
- Life expectancy <1 year due to non-cardiac conditions
- Patient appears unlikely or unable to participate in the required study procedures, as assessed by the study PI, study coordinator, or designee (ex: clinically-significant psychiatric, addictive, or neurological disease)
- Evidence of moderate to large area of ischemia on the PET
Egyéb feltételek
- Potential subjects must meet all of the following criteria to be eligible for inclusion in the study:
- General Inclusion Criteria:
- The patient is over 18 years of age
- The patient underwent orthotopic heart transplantation and is undergoing routine cardiac allograft vasculopathy (CAV) surveillance with PET
- The patient has no evidence of cardiogenic shock
- The patient has no evidence of acute rejection
- The patient, or legally authorized representative, has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent, approved by the appropriate Institutional Review Board (IRB) or Ethics Committee (EC); Potential subjects will be excluded if any of the following conditions apply:
Helyszínek itt: Egyesült Államok
- Yale New Haven HealthNew Haven, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this research study is to understand if a blood test in people who have had heart transplants can detect and predict the following:
A teljes eredeti leírásKevesebb
* Blockages in the small blood vessels of the heart. * Whether small blockages can turn into more severe blockages in the future.
Participants will undergo blood draws once every 3 months in the first year of the study (4 blood draws total, taking 15 minutes each) and their medical records will be reviewed for 3 years after the date they are enrolled in the study.
A vizsgálat 2 csoportja
- Low MFR (less than or equal to 1.5)
Subjects who are found to have a low MFR of less than or equal to 1.5.
Kezelés: Blood draw to measure the levels of dd-cf DNA
- Normal MFR (greater than 1.5)
Subjects who are found to have normal MFR of greater than 1.5.
Kezelés: Blood draw to measure the levels of dd-cf DNA
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- The DEPICT Prospective Study: Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury as Assessed by Donor Derived Cell Free DNA Post Transplantation
- A regiszteradat frissítve
- 2025. november 6.